In this BBC News segment, Prof. Robert Langer, winner of the Queen Elizabeth Prize for Engineering, discusses his work exploring how to get the human body to respond to vital drugs. Langer explains that his approach to medicine is to “come up with engineering solutions to different medical problems.”
MIT researchers have developed a self-sustaining water-purification system for a remote Mexican village, according to The Guardian. “The villagers are able to operate and maintain the water purification system themselves,” The Guardian reports.
Forbes reporter Jennifer Hicks writes about MIT spinoff EyeNetra, which is developing a self-diagnostic eye test could lead to customized, virtual-reality screens. “EyeNetra’s technology measures how a user’s optical refractive errors will affect how they see patterns on a digital display, just like a VR headset,” Hicks explains.
Lindsay Kalter reports for The Boston Herald that researchers from MIT, Philips, and Boston Medical Center are developing a non-invasive way to diagnose head injuries. Kalter explains that the study is part of a new collaboration between MIT and Philips and will “use data from an ultrasound machine taking measurements of blood pressure and flow.”
Researchers from MIT, Philips and Boston Medical Center are collaborating on new technology to diagnose brain injuries, reports Nidhi Subbaraman for BetaBoston. “The goal is to investigate whether ultrasound readers can help doctors assess the severity of a head injury,” Subbaraman writes.
In an article for The New York Times about the impact of patent laws on drug development, Austin Frakt highlights Prof. Benjamin Roin’s research that indicates pharmaceutical companies reject unpatentable drugs. To counter this problem, Frakt explains that Roin suggests “a period of market exclusivity…to any organization addressing an unmet medical need with a drug that isn’t patentable.”
Charlotte Lytton writes for The Daily Beast about SenseGlass, a mirror created by graduate student Javier Hernandez that uses Google Glass technology to register physiological and emotional changes in the viewer. “I believe mirrors are a great platform for health monitoring as we use them [everyday],” says Hernandez.
Margot Sanger-Katz of The New York Times writes about Professor Amy Finkelstein’s survey of low-income Oregonians in which she determined that those given access to Medicaid spent more on healthcare than the uninsured. “There’s overwhelming evidence from our study and others that when you cover people with health insurance, they use more health care,” said Finkelstein.
A new study on cancer drug development by MIT researchers found that pharmaceutical firms overlook drugs for early-stage tumors, writes Jordan Graham for The Boston Herald. “There’s dramatically more investments in the late-stage treatments,” says Prof. Benjamin Roin.
In a Scientific American podcast, Cynthia Graber examines MIT research showing typing speed can indicate if a person is fatigued and can help diagnose certain diseases. Typing speed could be used as a “safety feature on software programs for night shifts” or could diagnose Parkinson’s “by tracking changes in someone’s ability to manipulate the common keyboard.”
Mark Shanahan writes for The Boston Globe that the organizers of HUBweek, an innovation-themed festival designed to showcase Boston’s leadership in education, medicine, technology and the arts, gathered at a launch party last week. As part of HUBweek, MIT will host “Solve,” an event designed to bring together leaders in a variety of areas to tackle global challenges.
Researchers at MIT have developed software that tracks typing speed in order to help diagnose Parkinson’s disease, writes Alexandra Ossola for Popular Science. Ossola explains that the researchers "hope that this type test could eventually lead to earlier diagnoses of Parkinson’s.”
Steve Lohr of The New York Times writes about how allowing patients like brain cancer survivor and MIT graduate student Steven Keating greater access to their medical records can not only improve patient health, but also benefit medical research. The sharing of medical records could be a “huge crowdsourcing opportunity for research,” Keating explains.
Kevin McSpadden of Time reports on Panoply, a social networking platform developed by researchers from MIT and Northwestern that is aimed at helping users deal with anxiety and depression. Panoply teaches “users a therapeutic tool called cognitive reappraisal, which tries to get people to look at a problematic situation from different perspectives.”
Nidhi Subbaraman of BetaBoston writes about a new online networking tool developed by MIT researchers that has been found to be effective in helping people cope with anxiety and depression. Researchers found that those who used the tool were “writing about their issues much more."